PTX:ASX
Prescient Therapeutics Ltd
A$0.066
0.00%
(0.00) 1D
Oct 2, 5:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
75.49M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
75.49M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
Traders Union
·
33 minutes ago
Charlie Bilello: S&P 500 averages 12 percent yearly return since 1980 despite risk
The Motley Fool
·
19 minutes ago
Here's How Many Shares of VOO You'd Need for $500 in Monthly Dividends
InteractiveCrypto
·
5 hours ago
The S&P 500 Looks Strong. Underneath, October Looks Thin.
Forbes
·
6 hours ago
S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com